ClinicalTrials.gg
CompletedNCT06067204Updated Oct 20, 2026

Automatic Ventilation in Prehospital Resuscitation on OHCA

An interventional study of Automatic ventilation and Manual ventilation in Out-Of-Hospital Cardiac Arrest, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Oct 20, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
522
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital — 6 open to participants now, 7 under way, none of them phase 3. Out-of-Hospital Cardiac Arrest · National Taiwan University Hospital.

Started
2023
with 2 others
No phase
8 of 15
2 open now
Registered
9th of 15
by date

Among the 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital, this one is one of 3 that started in 2023, is one of 8 with no phase, and was the 9th registered.

Out-of-Hospital Cardiac Arrest

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

Browse Out-of-Hospital Cardiac Arrest studies →

Open to participants now

6 of the 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital, or all of them as a file.
02

Study summary

The goal of this randomized controlled trial is to compare prehospital ventilation strategies in out-of-hospital cardiac arrest. The intervention group is automatic ventilation and the control group is manual ventilation. The main questions it aims to answer are:

  1. How does automatic ventilation affect OHCA patients' survival and prognosis comparing to manual ventilation.
  2. What are the differences on resuscitation qualities between automatic ventilation and manual ventilation.
03

Conditions studied

  • Out-Of-Hospital Cardiac Arrest

Keywords

  • automatic ventilation
  • prehospital resuscitation
  • emergency medical service
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age over 18 years old at the time of occurrence of out-of-hospital cardiac arrest (OHCA).
  • Attended by the Hsinchu County Fire Department for emergency medical assistance.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women.
  • OHCA caused by trauma.
  • Return of spontaneous circulation (ROSC) observed at the scene.
  • Clearly deceased at the scene (reaching conditions such as decomposition, rigor mortis, severe burns, decapitation, evisceration, or trunk fracture).
  • Refusal of medical transportation by family members.
  • No placement of an advanced airway throughout the procedure.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
522 participants (actual)

Study arms

  • Experimental
    Automatic ventilation

    Patients treated by an EMS team during a 14-day period allocated to automatic ventilation (allocation by EMS team-period). After the advanced airway is placed, an automatic pneumatic ventilator is connected and delivers one breath every 6 seconds (10 breaths per minute).

    Device: Automatic ventilation

  • Active comparator
    Manual ventilation

    Patients treated by an EMS team during a 14-day period allocated to manual ventilation (allocation by EMS team-period). After the advanced airway is placed, a bag-valve resuscitator is connected and the emergency medical technician delivers one breath every 6 seconds (10 breaths per minute).

    Device: Manual ventilation

Interventions

  • DeviceAutomatic ventilation

    The device used is "Meditech" MICROVENT RESUSCITATOR, which is connected to the endotracheal tube, supraglottic airway or tracheostomy tube. It is powered by the airflow from the oxygen tank and provides ventilation in fixed interval. It has a pressure valve which will release the pressure once the airway pressure exceeds its threshold. In the current study, the threshold is set at 60 cmH2O. The tidal volume is set at 500-600 ml.

    Also known as: automatic pneumatic ventilation (APV)

  • DeviceManual ventilation

    The adult size bag-valve mask is connected to the endotracheal tube, supraglottic airway or tracheostomy tube. The interval, pressure and volume of the ventilation is controlled by the emergency medical technicians.

    Also known as: Bag-valve-mask (BVM) ventilation

06

What researchers measure

Primary outcomes

  1. The percentage of any return of spontaneous circulation (ROSC)

    The patient achieved ROSC in prehospital or inhospital resuscitation.

    Time frame: 2 hours

Secondary outcomes

  1. The percentage of sustained ROSC in 24 hours

    The patient survives for 24 hours after arriving the hospital.

    Time frame: up to 24 hours

  2. The percentage of survival to hospital discharge

    The patient survives to discharge from the hospital.

    Time frame: up to 90 days

  3. The percentage of favorable neurological outcome after discharge

    The patient survives to discharge from the hospital with Cerebral Performance Categories Scale 1 or 2.

    Time frame: up to 90 days

  4. Chest compression fraction

    The chest compression fraction during prehospital resuscitation recorded by the monitor.

    Time frame: up to 1 hour

  5. The percentage of intravenous catheter placement

    Whether the patient has an IV catheter placed in the prehospital setting.

    Time frame: up to 1 hour

  6. The percentage of epinephrine injection

    Whether the patient has epinephrine injected in the prehospital setting.

    Time frame: up to 1 hour

  7. The satisfaction of emergency medical technician (EMT) during the dispatch

    The outcome contained five questions: * More convenient to use * Shorter time required to complete ventilation (from advanced airway placement to the start of ventilation) * Smoother patient transport process * Ability to perform more emergency medical techniques * Overall satisfaction with the execution of emergency medical tasks The EMTs answer in the 5-level scale (highly disagree, disagree, neutral, agree, highly agree)

    Time frame: up to 5 hours

  8. The percentage of pneumothorax

    Unilateral, bilateral or tension pneumothorax which might be associated with the ventilation strategy.

    Time frame: up to 3 days

Other outcomes

  1. Ventilation rate in the prehospital resuscitation

    The ventilation rate recorded by the portable monitor with feedback sensor (BVM help).

    Time frame: up to 1 hour

  2. Tidal volume in the prehospital resuscitation

    The tidal volume recorded by the portable monitor with feedback sensor (BVM help).

    Time frame: up to 1 hour

  3. Chest compression depth in the prehospital resuscitation

    The chest compression depth recorded by the portable monitor with feedback pad.

    Time frame: up to 1 hour

  4. Chest compression rate in the prehospital resuscitation

    The chest compression rate recorded by the portable monitor with feedback pad.

    Time frame: up to 1 hour

  5. End-tidal carbon dioxide level (ETCO2)

    The ETCO2 recorded in the prehospital resuscitation process.

    Time frame: 1 hour

07

Study locations

1 site
  • National Taiwan University Hospital Hsinchu Branch
    Hsinchu, Taiwan
08

References and documents

Publications

  • Fan CY, Huang SS, Chen CH, Sung CW, Chang CH, Hung TH, Liu YC, Huang EP. Prehospital ventilation strategies in out-of-hospital cardiac arrest: A protocol for a randomized controlled trial (PIVOT trial). Resusc Plus. 2024 Nov 16;20:100827. doi: 10.1016/j.resplu.2024.100827. eCollection 2024 Dec. PubMed 39624188 ↗

Individual participant data

Plan to share: No

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2023 to primary completion in Aug 2025, 22 months.

Of 93 non-industry interventional studies with no phase under Out-of-Hospital Cardiac Arrest, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 57. This study's 22 months is below that.

Counting every sponsor, half of 95 studies reached it within 34 months; a quarter within 19 and three quarters within 57.

Primary completion moved twice since we started tracking on Sep 25, 2026: Mar 2026 → Aug 2025, last on Oct 20, 2026.

Completion moved once since we started tracking on Sep 25, 2026: Sep 2026 → Nov 2025, on Oct 8, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2023
First posted
Oct 4, 2023
StartActual
Oct 2, 2023
Primary completionActual
Aug 15, 2025was Mar 2026
CompletionActual
Nov 30, 2025was Sep 2026
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 8, 2026
Primary completion
Mar 31, 2026→Aug 15, 2025
moved 2 times, Oct 8, 2026 – Oct 20, 2026
Study completion
Sep 30, 2026→Nov 30, 2025 (actual)
Oct 8, 2026
Enrollment
514 (estimated)→522 (actual)
Oct 8, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 39624188 ↗
Oct 8, 2026
Show all 2 updates
  1. Oct 20, 2026
    Primary completion Oct 18, 2025→Aug 15, 2025
    + 2 other changes: oversight details and arm descriptions
  2. Oct 8, 2026
    Recruiting→Completed
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 39624188 ↗
    Primary completion Mar 31, 2026→Oct 18, 2025 (now actual)
    Study completion Sep 30, 2026→Nov 30, 2025 (now actual)
    Enrollment 514 (estimated)→522 (actual)
    + 6 other changes: verification date, design details, arm descriptions, contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06067204
Responsible party
Sponsor
First posted
Oct 4, 2023
Start date
Oct 2, 2023
Primary completion
Aug 15, 2025
Completion
Nov 30, 2025
Last update
Oct 20, 2026

Study contacts

Edward Pei-Chuan Huang, M.D., M.S.
study chair · National Taiwan University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion